Homology Medicines Inc
NASDAQ:QTTB

Watchlist Manager
Homology Medicines Inc Logo
Homology Medicines Inc
NASDAQ:QTTB
Watchlist
Price: 3.12 USD 2.97% Market Closed
Market Cap: 38.4m USD

Wall Street
Price Targets

QTTB Price Targets Summary
Homology Medicines Inc

Wall Street analysts forecast QTTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QTTB is 11.56 USD with a low forecast of 4.04 USD and a high forecast of 21 USD.

Lowest
Price Target
4.04 USD
29% Upside
Average
Price Target
11.56 USD
271% Upside
Highest
Price Target
21 USD
573% Upside
Homology Medicines Inc Competitors:
Price Targets
RARE
Ultragenyx Pharmaceutical Inc
145% Upside
SBTX
SkinBioTherapeutics PLC
117% Upside
ALNY
Alnylam Pharmaceuticals Inc
25% Upside
688331
RemeGen Co Ltd
17% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
35% Upside
TVTX
Travere Therapeutics Inc
20% Upside
688363
Bloomage Biotechnology Corp Ltd
10% Upside
OXB
Oxford BioMedica PLC
23% Upside

Revenue
Forecast

Revenue Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QTTB's stock price target?
Price Target
11.56 USD

According to Wall Street analysts, the average 1-year price target for QTTB is 11.56 USD with a low forecast of 4.04 USD and a high forecast of 21 USD.

Back to Top